A Study to Observe Characteristics of Rheumatoid Arthritis in Patients Using Infliximab (Study P04250)
Clinical trial NCT00705289 · COMPLETED
Trial details
- NCT number
- NCT00705289
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2005-12-01
- Primary completion
- 2008-09-01
- Enrollment
- 728
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.